Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community
- 1 May 1973
- journal article
- clinical trial
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 3 (2), 141-158
- https://doi.org/10.1017/s0033291700048480
Abstract
Synopsis: This paper reports the social results of a double-blind placebo controlled trial of fluphenazine decanoate. Among patients on placebo there was a deterioration in family relationships, which was due to an increase in aggression, noisiness, talking about delusions, and socially embarrassing behaviour after withdrawal of active drug.Keywords
This publication has 20 references indexed in Scilit:
- Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind PlaceboBMJ, 1973
- Dependence of schizophrenic patients on elderly relativesPsychological Medicine, 1972
- THE CONTRIBUTION OF FLUPHENAZINE ENANTHATE AND DECANOATE IN THE PREVENTION OF READMISSION OF SCHIZOPHRENIC PATIENTSActa Psychiatrica Scandinavica, 1971
- Trial of Maintenance Therapy in SchizophreniaBMJ, 1971
- FREQUENCY OF SEPARATION AND DIVORCE AMONG WOMEN AGED 16‐49 SUFFERING FROM SCHIZOPHRENIA AND AFFECTIVE DISORDERSActa Psychiatrica Scandinavica, 1970
- The Effect of Fluphenazine Enanthate on Chronic and Relapsing SchizophreniaThe British Journal of Psychiatry, 1969
- PROPHYLACTIC LITHIUM: ANOTHER THERAPEUTIC MYTH?The Lancet, 1968
- A Trial of Fluphenazine Enanthate in Chronic SchizophreniaThe British Journal of Psychiatry, 1967
- Do psyhiatric out-patients take their drugs?BMJ, 1965
- A FOLLOW‐UP OF SCHIZOPHRENIC PATIENTS IN EDINBURGHActa Psychiatrica Scandinavica, 1963